HRSA's Revised 340B Rebate Pilot Explained: What Claims-Based Rebates on 25 Negotiated Drugs Actually Change for Hospitals, Manufacturers, and TPAs, and Whether It Fixes 340B Transparency

Thoughts on Healthcare Markets & Technology Podcast

0:00

-7:03

Paid episode

The full episode is only available to paid subscribers of Thoughts on Healthcare Markets & Technology

HRSA's Revised 340B Rebate Pilot Explained: What Claims-Based Rebates on 25 Negotiated Drugs Actually Change for Hospitals, Manufacturers, and TPAs, and Whether It Fixes 340B Transparency

Aug 09, 2026

∙ Paid

HRSA just published a revised 340B rebate pilot. Hospitals that have bought drugs at a discount for 30 years now buy at full price and wait for a rebate. The mechanics of that shift are worth understanding.

The pilot covers roughly 25 drugs from 13 manufacturers, drawn from the Medicare price negotiation lists for 2026 and 2027. HRSA says those products …

Continue reading this post for free, courtesy of Thoughts on Healthcare.

Or purchase a paid subscription.